Non-invasive markers of inflammation in autoimmune hepatitis

Liver International

Volumn 33, Issue 9, 2013, Pages 1295-1297

  Fabbri, Angela ^a   Lenzi, Marco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; ELASTOGRAPHY; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; HYPERGAMMAGLOBULINEMIA; HYPERTRANSAMINASEMIA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LABORATORY TEST; LIVER BIOPSY; LIVER FIBROSIS; LIVER PARENCHYMA; MORTALITY; PRACTICE GUIDELINE; REMISSION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT;

BIOLOGICAL MARKERS; GAMMA-GLOBULINS; HEPATITIS, AUTOIMMUNE; HUMANS; REMISSION INDUCTION; RESEARCH DESIGN; TRANSAMINASES;

EID: 84883806804     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12251     Document Type: Article

References (19)

1. Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and Management of autoimmune hepatitis. Hepatology 2010; 51: 2193-213.
2. Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
3. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis Hepatology 2002; 36: 479-97.
4. Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. QJM 1971; 40: 159-85.
5. Soloway RD, Summerskill WH, Baggenstoss AH, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 1972; 63: 820-33.
6. Murray-Lyon IM, Stern RB, William R. Controlled triasl of prednisone and azathioprine in active chronic epatitis. Lancet 1973; 1: 735-7.
7. Czaja AJ. Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology 2005; 41: 207-15.
8. Miyake Y, Iwasaki Y, Terada R, et al. J Hepatol 2005; 43: 951-7.
9. Montano-Loza AJ, Carpenter HA, Czaja AJ. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse. Am J Gastroenterol 2007; 102: 1005-12.
10. Verma S, Gunuwan B, Mendler M, Govindrajan S, Redeker A. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission, and plasma cell activity in the liver biopsy. Am J Gastroenterol 2004; 99: 1510-6.
11. Muratori P, Granito A, Quarneti C, et al. Autoimmune hepatitis in Italy: the Bologna experience. J Hepatol 2009; 50: 1210-8.
12. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey For the Group of Epidemiology of the French Association for the Study of the Liover (AFEF). Hepatology 2000; 32: 477-81.
13. Lüth S, Herkel J, Kanzler S, et al. Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis. J Clin Gastroenterol 2008; 42: 926-30.
14. Gomez-Domininguez E, Mendoza J, Rubio S, et al. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther 2006; 24: 513-8.
15. Noriyuki O, Yoshiyuki U, Fukushima K, et al. Transient elastogrphy for mesurement of liver stiffness can detect early significant hepatic fibrosis in japanese patients with viral and nonviral disease. J Gatroenterol 2008; 43: 720-8.
16. Wang QX, Shen L, Qiu DK, et al. Validation of transient elastography (Fibroscan) in assessment of hepatic fibrosis in autoimmune hepatitis. ZhoNhua Gan Zang Bing Za Zhi 2011; 19: 782-4.
17. Anastasiuo J, Alisa A, Virtue S, et al. Noninvasive markers of fibrosis and inflammation in clinical practice: propsective comparison with liver biopsy. Eur J Gastroenterol Hepatol 2010; 22: 474-80.
18. Hennes EM, Zeniya M, Czaja AJ, et al.; International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008; 48:169-76.
19. Czaja Aj, Wolf AM, Baggenstoss AH. Laboratory assessment of severe chronic active liver disease (CALD): correlation of serum transaminasi and gamma globulin levels with histologic features. Gastroenterology 1981; 80: 687-92.